Efficacy and Safety of Oral PCSK9 Inhibitors: Insights from a Meta-analysis of RCTS.

laroprovstat (AZD0780) - AstraZeneca

Leqvio (inclisiran) - Novartis

Praluent (alirocumab) - Sanofi, Regeneron

Repatha (evolocumab) - Amgen, Astellas

NNC0385-0434 - Novo Nordisk

http://www.ncbi.nlm.nih.gov/pubmed/42169510

Alberico L Catapano; Elena Olmastroni; Federica Galimberti; Manuela Casula; Sining Xie

May 23, 2026